Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis
Clinical trial NCT01569074 · TERMINATED
Trial details
- NCT number
- NCT01569074
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-07-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.